![]() |
Volumn 847, Issue 1, 2007, Pages 38-44
|
Validation of an HIV-1 inactivation protocol that is compatible with intracellular drug analysis by mass spectrometry
|
Author keywords
Antiviral; HIV; Inactivation; Infectious; Intracellular; MALDI
|
Indexed keywords
BIOMEDICAL ENGINEERING;
CELLS;
DRUG PRODUCTS;
IONIZATION;
MASS SPECTROMETRY;
ANTIVIRAL;
HIV;
INTRACELLULAR;
MALDI;
VIRUSES;
ALCOHOL;
ANTIRETROVIRUS AGENT;
METHANOL;
RITONAVIR;
ACCURACY;
ARTICLE;
BIOSAFETY;
CELL ISOLATION;
DRUG DETERMINATION;
DRUG ISOLATION;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MASS SPECTROMETRY;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
SUPERNATANT;
TITRIMETRY;
VIRUS INACTIVATION;
VIRUS INFECTIVITY;
ANTI-HIV AGENTS;
CELL EXTRACTS;
CELLS, CULTURED;
ETHANOL;
HIV-1;
HUMANS;
METHANOL;
RITONAVIR;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;
VIRUS INACTIVATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 33846807607
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2006.10.001 Document Type: Article |
Times cited : (11)
|
References (22)
|